13F-HR filed by Carlyle Group Inc.
Carlyle Group Inc. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-04, with 26 holding rows worth $2,807,308,291.
- Accession
- 0000898432-23-000571
- Filer
- CIK 1527166
- Filed
- 2023-08-04
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A combination report, 27 entries on the cover page, a total value of $2,807,308,291 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,807,308,291 with VALUE read as dollars as filed, 13F file number 028-15025. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerAlpInvest Partners B.V.028-15646
- included managerAbingworth LLP028-14285
- included managerCarlyle Investment Management LLC028-12429
- included managerCIM Global, L.L.C.028-15024
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| QUIDELORTHO CORP COM | 219798105 | Stock | 12,460,183 | $1,032,450,763 | dollars as filed | |
| ZOOMINFO TECHNOLOGIES INC COMMON STOCK | 98980F104 | Stock | 36,662,469 | $930,860,088 | dollars as filed | |
| MKS INC. COM | 55306N104 | Stock | 3,482,732 | $376,483,329 | dollars as filed | |
| VITRU LTD | G9440D103 | COM | 6,246,471 | $100,130,930 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,457,500 | $51,877,825 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 3,496,808 | $50,074,291 | dollars as filed | |
| GETTY IMAGES HOLDINGS INC | 374275105 | CL A COM | 9,976,300 | $48,684,344 | dollars as filed | |
| GDS HLDGS LTD SPONSORED ADS | 36165L108 | ADR | 4,072,624 | $44,758,142 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,416,837 | $38,766,065 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,838,486 | $31,530,035 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 2,698,957 | $17,678,168 | dollars as filed | |
| INVITATION HOMES INC COM | 46187W107 | REIT | 477,500 | $16,426,000 | dollars as filed | |
| SEACOR MARINE HLDGS INC COM | 78413P101 | Stock | 1,314,164 | $15,020,895 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 8,761,891 | $11,828,553 | dollars as filed | |
| CUBESMART COM | 229663109 | REIT | 220,500 | $9,847,530 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 2,896,518 | $6,227,514 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 2,115,385 | $5,119,232 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,201,506 | $5,094,385 | dollars as filed | |
| SMART SH GLOBAL LTD | 83193E102 | ADS | 4,810,209 | $4,689,593 | dollars as filed | |
| EFFECTOR THERAPEUTICS INC | 28202V108 | COM | 4,822,114 | $3,954,133 | dollars as filed | |
| NUCANA PLC | 67022C106 | ADR | 3,333,333 | $2,600,000 | dollars as filed | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 1,041,131 | $2,300,900 | dollars as filed | |
| EXICURE INC | 30205M200 | COM NEW | 281,636 | $368,943 | dollars as filed | |
| META DATA LIMITED | 68276W400 | SPONSORED ADS | 314,400 | $336,408 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 240,500 | $108,225 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 200,000 | $92,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000898432-23-000571 | this filing | 2023-08-04 | acceptance time not in the bulk data set |